1![Final Results of a Phase II Multicenter Trial of HF10, a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab Combination Treatment in Patients with Stage IIIB-IV Unresectable or Metastatic Melanoma Abstract #1664 Final Results of a Phase II Multicenter Trial of HF10, a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab Combination Treatment in Patients with Stage IIIB-IV Unresectable or Metastatic Melanoma Abstract #1664](https://www.pdfsearch.io/img/d024aea164d198460a43aba37f726661.jpg) | Add to Reading ListSource URL: www.takara-bio.co.jpLanguage: English - Date: 2017-06-02 05:25:57
|
---|
2![Tumor response from Phase II study of combination treatment of intratumoral HF10, a replication - competent HSV-1 oncolytic virus, and ipilimumab in patients with stage IIIB, IIIC, or IV unresectable or metastatic melano Tumor response from Phase II study of combination treatment of intratumoral HF10, a replication - competent HSV-1 oncolytic virus, and ipilimumab in patients with stage IIIB, IIIC, or IV unresectable or metastatic melano](https://www.pdfsearch.io/img/19a53c86a844b2480dd60b81d9517bab.jpg) | Add to Reading ListSource URL: www.takara-bio.co.jpLanguage: English - Date: 2016-10-24 01:27:48
|
---|
3![When Patients Win, We All Win™ Provectus Biopharmaceuticals, Inc Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigation When Patients Win, We All Win™ Provectus Biopharmaceuticals, Inc Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigation](https://www.pdfsearch.io/img/cf39b5c4897d5a16feeb4ba04a676a0a.jpg) | Add to Reading ListSource URL: www.pvct.comLanguage: English - Date: 2016-08-18 16:04:23
|
---|
4![Intralesional therapy is a possible treatment option for patients with metastatic melanoma due to its good local response and tolerable adverse-event profile. Photo courtesy of Dina Potter. Sunny Tree. 48 Intralesional therapy is a possible treatment option for patients with metastatic melanoma due to its good local response and tolerable adverse-event profile. Photo courtesy of Dina Potter. Sunny Tree. 48](https://www.pdfsearch.io/img/8a9aa5d8249fb32f44ca06c05964b734.jpg) | Add to Reading ListSource URL: moffitt.orgLanguage: English - Date: 2016-03-02 10:23:54
|
---|
5![OVC Crestword copy black read OVC Crestword copy black read](https://www.pdfsearch.io/img/a10a78705c1f51f22f8e213c46ef6d40.jpg) | Add to Reading ListSource URL: www.smilingblueskies.comLanguage: English - Date: 2016-01-22 12:27:43
|
---|
6![FOR
IMMEDIATE
RELEASE
FOR
IMMEDIATE
RELEASE](https://www.pdfsearch.io/img/97f4eacc475788d231a92959e46e58f6.jpg) | Add to Reading ListSource URL: www.versantventures.comLanguage: English - Date: 2016-01-27 13:02:32
|
---|
7![WORLD PRECLINICAL CONGRESS June 14-17, 2016 Westin Boston Waterfront, Boston, MA WORLD PRECLINICAL CONGRESS June 14-17, 2016 Westin Boston Waterfront, Boston, MA](https://www.pdfsearch.io/img/59de2b98d515d44e9628bbdc2d1cb219.jpg) | Add to Reading ListSource URL: www.worldpreclinicalcongress.comLanguage: English - Date: 2016-04-07 10:46:41
|
---|
8![F E AT U R E Gene therapy finds its niche Cormac Sheridan Gene therapy is finally poised to make a contribution to the treatment of debilitating, highly penetrant genetic diseases that have proved intractable to other r F E AT U R E Gene therapy finds its niche Cormac Sheridan Gene therapy is finally poised to make a contribution to the treatment of debilitating, highly penetrant genetic diseases that have proved intractable to other r](https://www.pdfsearch.io/img/c5fa0d2249e07255bca1968624a8dadc.jpg) | Add to Reading ListSource URL: www.wissenschaftsdialog.deLanguage: English - Date: 2012-03-01 05:18:48
|
---|
9![Late Breaking Abstracts Addendum
Late Breaking Abstracts: Presented at the American Society of Gene & Cell Therapy’s 16th Annual Meeting, May 15-18, 2013, Salt Lake City, Utah Late Breaking Abstracts Addendum
Late Breaking Abstracts: Presented at the American Society of Gene & Cell Therapy’s 16th Annual Meeting, May 15-18, 2013, Salt Lake City, Utah](https://www.pdfsearch.io/img/e71a3313eb2064d084ef6c5c0e1ac31e.jpg) | Add to Reading ListSource URL: www.asgct.orgLanguage: English - Date: 2013-05-10 11:29:09
|
---|
10![Microsoft Word - ITOC1_Final_programme Microsoft Word - ITOC1_Final_programme](https://www.pdfsearch.io/img/c38030a34915813316c6e6150f9bb7b6.jpg) | Add to Reading ListSource URL: itoc-conference.euLanguage: English - Date: 2014-09-09 08:02:55
|
---|